Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
						
					
								- 
								Ito Fukunaga M, Wiener RS, Toomey S, Wagner J, Shi Q, Balakrishnan K, Nguyen A, Nguyen D, McKee MD, Bankier AA, Sadasivam RS, Crawford SL, Han PK, Houston TK, Mazor KM. Previsit Preparation for Shared Decision-Making in Lung Cancer Screening in Primary Care Using a Paper Decision Aid and an Automated Text Messaging Program: Quasi-Experimental Pilot Study. JMIR Form Res. 2025 Sep 17; 9:e69044. 
- 
								Reddington H, Ballinger Z, Guart J, Emmerick I, Crawford A, Maxfield M, Uy K, Lou F. National adoption of robotic-assisted thoracoscopic surgery for oncologic lung resections. J Robot Surg. 2025 Sep 04; 19(1):557. 
- 
								Lo SB, Shin J, Holtze ME, Post KE, Eche-Ugwu IJ, Temel JS, Cooley ME, Greer JA. Characterization of multidimensional dyspnea in advanced lung cancer with moderate to severe dyspnea-related functional impairment: a latent profile analysis. Support Care Cancer. 2025 Jul 18; 33(8):700. 
- 
								Chung C, Lee KN, Shin DW, Lee SW, Han K. Serum ?-glutamyl transferase as a novel risk indicator for lung cancer: insights from four million Koreans. Respir Res. 2025 Jul 10; 26(1):242. 
- 
								Kant S, Caliz AD, Yoo HJ, Kaur G, Learnard H, Khalil HA, Davis RJ, Keaney JFJ. Mixed lineage kinase (MLK) controls tumor development and angiogenesis. Angiogenesis. 2025 May 02; 28(3):29. 
- 
								Nasasra A, Mamman R, Hershkovitz Y, Zager Y, Lavy R. [RECTUS ABDOMINIS MASS AS THE FIRST PRESENTATION OF LUNG ADENOCARCINOMA]. Harefuah. 2025 May; 164(5):289-291. 
- 
								Famiyeh L, Chen K, Tesema FB, Kelly C, Ji D, Xiao H, Tong L, Wang Z, He J. Refining source-specific lung cancer risk assessment from PM2.5-bound PAHs: Integrating component-based potency factors and machine learning in Ningbo, China. Ecotoxicol Environ Saf. 2025 Jun 01; 297:118174. 
- 
								Dora D, Revisnyei P, Pasic A, Galffy G, Dulka E, Mihucz A, Rosk? B, Szincsak S, Iliuk A, Weiss GJ, Lohinai Z. Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients. Front Immunol. 2025; 16:1543817. 
- 
								Lo SB, Holtze M, Post KE, Eche-Ugwu IJ, Cooley ME, Pirl WF, Temel JS, Greer JA. Depression and Anxiety as Moderators for a Behavioral Treatment for Dyspnea in Advanced Lung Cancer. J Pain Symptom Manage. 2025 Aug; 70(2):e121-e128. 
- 
								Nourmohammadi M, Rahimi Moghadam S, Jalalian Moghadam A, Yari S. Assessment of Cancer Rate in Mine Workers Exposed to Crystalline Silica. Asian Pac J Cancer Prev. 2025 Apr 01; 26(4):1173-1179.